LAIX INC - ADR (LAIX) Fundamental Analysis & Valuation

NYSE:LAIX

Current stock price

3.1
-0.33 (-9.62%)
Last:

This LAIX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. LAIX Profitability Analysis

1.1 Basic Checks

  • In the past year LAIX has reported negative net income.
LAIX Yearly Net Income VS EBIT VS OCF VS FCFLAIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 -100M -200M -300M -400M -500M

1.2 Ratios

Industry RankSector Rank
ROA -26.97%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LAIX Yearly ROA, ROE, ROICLAIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 100 -100 200 -200

1.3 Margins

Industry RankSector Rank
OM -10.58%
PM (TTM) -9.27%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LAIX Yearly Profit, Operating, Gross MarginsLAIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. LAIX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, LAIX has more shares outstanding
  • LAIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LAIX Yearly Shares OutstandingLAIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 200M 400M 600M
LAIX Yearly Total Debt VS Total AssetsLAIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -9.28, we must say that LAIX is in the distress zone and has some risk of bankruptcy.
  • There is no outstanding debt for LAIX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.28
ROIC/WACCN/A
WACCN/A
LAIX Yearly LT Debt VS Equity VS FCFLAIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 200M -200M -400M -600M

2.3 Liquidity

  • LAIX has a Current Ratio of 0.20. This is a bad value and indicates that LAIX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • LAIX has a Quick Ratio of 0.20. This is a bad value and indicates that LAIX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
LAIX Yearly Current Assets VS Current LiabilitesLAIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. LAIX Growth Analysis

3.1 Past

  • LAIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.21%, which is quite impressive.
  • The Revenue for LAIX has decreased by -13.96% in the past year. This is quite bad
  • Measured over the past years, LAIX shows a very strong growth in Revenue. The Revenue has been growing by 198.20% on average per year.
EPS 1Y (TTM)114.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.97%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y80.42%
Revenue growth 5Y198.2%
Sales Q2Q%-33.38%

3.2 Future

  • Based on estimates for the next years, LAIX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.84% on average per year.
  • LAIX is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.75% yearly.
EPS Next Y99.57%
EPS Next 2Y41.34%
EPS Next 3Y25.97%
EPS Next 5Y14.84%
Revenue Next Year-27.88%
Revenue Next 2Y-22.1%
Revenue Next 3Y-16.08%
Revenue Next 5Y-13.75%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LAIX Yearly Revenue VS EstimatesLAIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
LAIX Yearly EPS VS EstimatesLAIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

1

4. LAIX Valuation Analysis

4.1 Price/Earnings Ratio

  • LAIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year LAIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LAIX Price Earnings VS Forward Price EarningsLAIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -13.56
LAIX Per share dataLAIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

  • LAIX's earnings are expected to grow with 25.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.34%
EPS Next 3Y25.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LAIX Dividend Analysis

5.1 Amount

  • LAIX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

LAIX Fundamentals: All Metrics, Ratios and Statistics

LAIX INC - ADR

NYSE:LAIX (4/7/2022, 8:04:00 PM)

3.1

-0.33 (-9.62%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)03-01
Earnings (Next)04-25
Inst Owners4.6%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap154.68M
Revenue(TTM)852.86M
Net Income(TTM)-79.08M
Analysts40
Price Target18.56 (498.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.16
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -13.56
EPS(TTM)-10.02
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.68
BVpS-2.13
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -10.58%
PM (TTM) -9.27%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z -9.28
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.97%
EPS Next Y99.57%
EPS Next 2Y41.34%
EPS Next 3Y25.97%
EPS Next 5Y14.84%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y80.42%
Revenue growth 5Y198.2%
Sales Q2Q%-33.38%
Revenue Next Year-27.88%
Revenue Next 2Y-22.1%
Revenue Next 3Y-16.08%
Revenue Next 5Y-13.75%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

LAIX INC - ADR / LAIX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LAIX INC - ADR (LAIX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LAIX.


What is the valuation status of LAIX INC - ADR (LAIX) stock?

ChartMill assigns a valuation rating of 0 / 10 to LAIX INC - ADR (LAIX). This can be considered as Overvalued.


Can you provide the profitability details for LAIX INC - ADR?

LAIX INC - ADR (LAIX) has a profitability rating of 1 / 10.


How financially healthy is LAIX INC - ADR?

The financial health rating of LAIX INC - ADR (LAIX) is 1 / 10.